Finland · Delayed Price · Currency is EUR Detection Technology Oyj Earnings Call Transcripts
Fiscal Year 2025
-
Q4 sales declined 6% year-over-year, mainly due to FX, with strong medical growth offset by declines in security and industrial. Double-digit sales growth is guided for Q1 and H1, driven by volume increases across all segments, while margins remain under pressure from product mix and competition.
-
The 2030 strategy targets 10% annual growth by expanding TFT flat panel detectors, leveraging a full in-house technology portfolio, and focusing on customer-centric innovation. Growth is expected across medical, security, and industrial markets, with a strong presence in APAC and new manufacturing in India.
-
Sales declined 7% in Q2, mainly due to forex and regulatory delays, but market position held firm. Industrial and medical segments grew, while security and EMEA sales dropped sharply. Outlook calls for single-digit sales decline in H2, with recovery in security expected next year.
Fiscal Year 2024
-
Q4 saw modest sales growth and a strong EBITDA margin, with full-year net profit doubling and robust cash flow. Security led segment performance, while medical is expected to drive double-digit growth in Q2 2024. Price competition in China and tariff risks remain key uncertainties.
-
Q2 net sales grew 3.5% year-over-year to EUR 26.1 million, with EBIT margin improving to 12.7%. Security and industrial segments drove growth, while medical sales lagged due to China reforms. Double-digit growth is expected for Q3 and H2.